Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats-Reference-Cited by-同舟云学术

Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats

Published:2009-01 Issue: Volume:1247 Page:182-187
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Shimoshige Yukinori,Minoura Kyoko,Matsuoka Nobuya,Takakura Shoji,Mutoh Seitaro,Kamijo Mikiko

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference39 articles.

1. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat;Ao;Metabolism,1991

2. Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy;Bril;Diabetes Care,2006

3. Natural progression of diabetic peripheral neuropathy in the zenarestat study population;Brown;Diabetes Care,2004

4. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose–response considerations and independence from a myo-inositol mechanism;Cameron;Diabetologia,1994

5. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy;Fernyhough;Diabetes,1999

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aldose reductase is a potential therapeutic target for neurodegeneration;Chemico-Biological Interactions;2024-02

2. Synthesis of 3-(Pyridin-2-yl)quinazolin-2,4(1H,3H)-diones via Annulation of Anthranilic Esters with N-pyridyl Ureas;International Journal of Molecular Sciences;2023-04-21

3. Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus;Antiviral Research;2023-01

4. Strategies in synthetic design and structure–activity relationship studies of novel heterocyclic scaffolds as aldose reductase‐2 inhibitors;Archiv der Pharmazie;2022-09-20

5. Physiological and Pathological Roles of Aldose Reductase;Metabolites;2021-09-27